RUOResearch reference
CJC-1295
Purity and third-party testing: no batch record published. Check the COA library.
Sold for laboratory research. Not for human consumption.
Pricing: view the storeOrder from norteava.com
Material specifications
| CAS number | Not published for the exact supplied form |
|---|---|
| Molecular formula | Not published for the exact supplied form |
| Sequence / identity | Not published for the exact supplied form |
| Molecular weight | Not published for the exact supplied form |
| Appearance | Not published for the exact supplied form |
| Solubility | Not published for the exact supplied form |
| Storage temperature | Not published for the exact supplied form |
| Batch number | Not published for the exact supplied form |
| COA | No published batch certificate |
Research context
CJC-1295 is described in the literature as a growth-hormone-releasing-hormone analogue with an albumin-binding design. The modification is part of the studied chemical identity.
A catalogue descriptor such as “no DAC” does not establish equivalence to that construct. Sequence, terminal chemistry and binding modification should be recorded before comparing experimental behavior.
Consult the original source for the model, comparator and measurement method. No preparation procedure, personal-use protocol or dosing recommendation is provided here.
Original-source reading
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog